News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-17 10:21:50 pm Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion SeekingAlpha
2024-03-08 12:5:7 pm Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2023 Earnings Call Transcript Insider Monkey
2024-03-07 10:57:12 pm Q4 2023 Phathom Pharmaceuticals Inc Earnings Call Thomson Reuters StreetEvents
2024-03-07 10:38:8 am Phathom Pharmaceuticals Inc (PHAT) Reports Q4 and Full Year 2023 Financials, Eyes Growth with ... GuruFocus.com
2024-03-07 5:0:0 am Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update GlobeNewswire
2024-02-29 5:0:0 am Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024 GlobeNewswire
2024-02-13 5:0:0 am Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients GlobeNewswire
2024-01-31 5:0:0 am Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference GlobeNewswire
2024-01-28 4:26:26 am With 47% ownership, Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) has piqued the interest of institutional investors Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information